By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Horizon Pharma plc. (Formerly Known As Horizon Pharma, Inc.) 

1033 Skokie Boulevard
Suite 355
Northbrook  Illinois  60062  U.S.A.
Phone: 224-383-3000 Fax: 224-383-3001


Company News
Horizon Pharma plc.  (HZNP) To Host Third Quarter 2014 Conference Call And Webcast On November 6, 2014 10/23/2014 11:43:13 AM
Horizon Pharma plc.  (HZNP) Reviews Future ACTIMMUNE® Opportunities At Analyst Day 10/17/2014 10:51:25 AM
Horizon Pharma plc.  (HZNP) Announces Presentation Of ACTIMMUNE(R) Phase 2 Data In Friedreich's Ataxia 10/9/2014 12:33:18 PM
Horizon Pharma plc.  (HZNP) Receives Orphan-Drug Designation For ACTIMMUNE(R) (Interferon gamma-1b) In Friedreich's Ataxia 10/6/2014 9:50:27 AM
Horizon Pharma plc.  (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of Additional Notice Of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets 10/2/2014 10:52:09 AM
Horizon Pharma plc.  (HZNP) Commercial Chief Resigns; Executive Committee Formed 9/29/2014 7:24:33 AM
Horizon Pharma plc.  (HZNP) To Host Friedreich's Ataxia Analyst Day On October 13, 2014 9/24/2014 9:16:06 AM
Horizon Pharma plc.  (HZNP) To Present At The 21st Annual NewsMakers In The Biotech Industry Conference 9/23/2014 1:17:27 PM
Horizon Pharma plc.  (HZNP) Completes Acquisition Of Vidara Therapeutics 9/22/2014 11:14:22 AM
Horizon Pharma plc.  (HZNP) Announces Board Of Directors Following Closing Of Acquisition Of Vidara Therapeutics International plc 9/19/2014 11:49:02 AM